Zhao Ni
Santi Martini
Erin M. Spaulding
Arief Hargono
Seth Shay Martin- 1School of Nursing, Yale University, New Haven, CT, United States
- 2Yale Institute for Global Health, Yale University, New Haven, CT, United States
- 3Faculty of Public Health, Airlangga University, Surabaya, Indonesia
- 4School of Nursing, Johns Hopkins University, Baltimore, MD, United States
- 5The Johns Hopkins Hospital, Johns Hopkins Medicine, Baltimore, MD, United States
Editorial on the Research Topic
Future trends and directions of using mHealth strategies to prevent and treat cardiovascular diseases
Preventing and treating cardiovascular diseases is of paramount importance, given their status as the leading cause of death worldwide (1). Unlike other diseases that are disproportionately influenced by social-demographic, ethnic, and geopolitical factors, cardiovascular diseases prevail as the primary cause of death across sexes and racial/ethnic groups in both developing and developed countries (1). For example, in the United States, cardiovascular diseases account for 20% (2–4) of all deaths and cost about $239.9 billion yearly (4, 5). Tragically, every 33 s a person succumbs to cardiovascular diseases (2, 4). In China, cardiovascular diseases cause nearly 4 million deaths annually (6) and impose a substantial economic burden on society (7, 8) due to heightened healthcare expenditures and productivity losses. Consequently, innovations in preventing and treating cardiovascular diseases hold immense significance on a global scale.
Mobile health, commonly known as mHealth, refers to the use of portable electronic devices with software applications to deliver health services and manage patient information (8–11). Studies have demonstrated the potential of mHealth in preventing cardiovascular diseases and supporting cardiovascular rehabilitation (8, 12–16). By providing personalized and real-time motivation and care, mHealth caters to the needs of people at high risk of developing cardiovascular diseases or those living with such conditions. Our proposed Research Topic, titled “Future trends and directions of using mHealth strategies to prevent and treat cardiovascular diseases” aims to capture the current status of mHealth strategies for cardiovascular diseases prevention and treatment in real clinical and community settings. We received a total of seven manuscripts and accepted four of them, which collectively provided valuable insights into current mHealth limitations and future directions.
Firstly, while the effectiveness of leveraging mHealth to promote cardiovascular health has been established, there is a scarcity of research focused on developing metrics to assess engagement with mHealth interventions as well as their feasibility, acceptability, and usability. A paper from Germany found that existing studies often employ self-defined questionnaires, followed by usage logs and interviews, as the primary tools for measuring these criteria. However, the validity and reliability of these self-defined instruments are often not established. There is a lack of recognized standards for evaluating mobile apps for cardiovascular diseases, primarily due to the complexity of cardiovascular diseases, which involve diverse risk factors and patient health needs. Although some guidelines have been issued for evaluating digital health interventions, such as the World Health Organization's guidelines titled “Recommendations on Digital Interventions for Health System Strengthening” (17), there is still a need for greater adoption and tailoring of such standards for mHealth studies in cardiovascular diseases. To address this gap, further research is needed to create more standardized evaluation instruments that can effectively measure the impact of mHealth interventions.
Secondly, another notable limitation in current research on mHealth is the inadequate reporting of the design and development process of mHealth interventions. While many studies focus on reporting outcomes, few provide details on their design and development. This gap hinders the adoption of mHealth interventions in the field of cardiovascular diseases. Studies from Australia and China emphasize the need for reporting the intricate design and development details of mHealth interventions. Furthermore, they discuss the importance of using a user-centered design approach in the development and implementation of mHealth interventions for cardiovascular diseases by involving key stakeholders, such as patients, healthcare professionals, and family members. We anticipate that future mHealth interventions will integrate new technologies, including artificial intelligence, machine learning, deep learning, virtual reality, augmented reality, and chatbot technology with traditional mobile technologies such as smartphone applications, wearables, web browsers/dashboards, and text messaging. These advancements aim to enhance the effectiveness of mHealth interventions and promote their capabilities to address individual concerns within the complex real-world environment. Researchers should consider including cost-effectiveness analysis as an important criterion to measure the effectiveness of mHealth interventions, in addition to traditional health outcomes such as blood pressure, readmission rates, and mortality. By incorporating such analysis, researchers enable policymakers and healthcare professionals to make informed decisions regarding the benefits of mHealth interventions. This, in turn, may propel the implementation of mHealth interventions in real-world settings.
Additionally, infodemiology has emerged as a prominent area of interest in mHealth research. As people commonly search for information online to prevent and treat cardiovascular diseases, harnessing the potential of infodemiology has become crucial to understanding how people access and engage with health information online. Researchers can gain valuable insight into users' behaviors, information gaps, and potential avenues for improving the dissemination of accurate and reliable information. A study in Malaysia developed an online platform to record the information patients search for and empower the public to appraise topic-specific health information. Future research should explore methods to incorporate infodemiology into mHealth interventions to empower individuals to make informed decisions and establish a framework for tailored interventions to address specific informational needs.
In conclusion, this Research Topic aims to address limitations and explore the current status of mHealth strategies in real clinical and community settings. By examining effectiveness, design and development, integration of new technologies, and infodemiology, we aim to contribute to the advancement and implementation of mHealth interventions for cardiovascular diseases.
Author contributions
ZN drafted the initial version of the manuscript. All authors contributed to the article and approved the submitted version.
Acknowledgments
We thank all reviewers participated in this Research Topic for their efforts and time.
Conflict of interest
ES is a consultant to Corrie Health. SSM is a founder of and holds equity in Corrie Health.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. (2020) 76:2982–3021. doi: 10.1016/j.jacc.2020.11.010
2. Centers for Disease Control and Prevention. “National Center for Health Statistics,” in Multiple Cause of Death 2018–2021 on CDC WONDER Database. (2023). Available online at: https://wonder.cdc.gov/mcd.html (accessed June 18, 2023).
3. Tsao CW, Aday AW, Almarzooq ZI, Anderson A, Arora P, Avery CL, et al. Heart disease and stroke statistics−2023 update: a report from the american heart association. Circulation. (2023) 147:e93–e621. doi: 10.1161/CIR.0000000000001123
4. Centers for Disease Control Prevention. Heart Disease Facts. (2023). Available online at: https://www.cdc.gov/heartdisease/facts.htm (accessed June 18, 2023).
5. Centers for Disease Control and Prevention. “National Center for Health Statistics,” in Percentage of Coronary Heart Disease for Adults Aged 18 and Over, United States, 2019−2021. (2023). Available online at: https://wwwn.cdc.gov/NHISDataQueryTool/SHS_adult/index.html (accessed Juen 18, 2023).
6. Li X, Wu C, Lu J, Chen B, Li Y, Yang Y, et al. Cardiovascular risk factors in China: a nationwide population-based cohort study. Lancet Public Health. (2020) 5:e672–81. doi: 10.1016/S2468-2667(20)30191-2
7. Le C, Fang Y, Linxiong W, Shulan Z, Golden AR. Economic burden and cost determinants of coronary heart disease in rural southwest China: a multilevel analysis. Public Health. (2015) 129:68–73. doi: 10.1016/j.puhe.2014.11.002
8. Ni Z, Wu B, Yang Q, Yan LL, Liu C, Shaw RJ. An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. J Med Internet Res. (2022) 24:e27202. doi: 10.2196/27202
9. Ventola CL. Mobile devices and apps for health care professionals: uses and benefits. P T. (2014) 39:356–64.
10. Boulos MN, Brewer AC, Karimkhani C, Buller DB, Dellavalle RP. Mobile medical and health apps: state of the art, concerns, regulatory control and certification. Online J Public Health Inform. (2014) 5:229. doi: 10.5210/ojphi.v5i3.4814
11. Vital Wave Consulting. mHealth for Development: the Opportunity of Mobile Technology for Healthcare in the Developing World. Washington, DC; Berkshire: UN Foundation-Vodafone Foundation Partnership (2019).
12. Subedi N, Rawstorn JC, Gao L, Koorts H, Maddison R. Implementation of Telerehabilitation Interventions for the Self-Management of Cardiovascular Disease: Systematic Review. JMIR Mhealth Uhealth. (2020) 8:e17957. doi: 10.2196/17957
13. Ni Z, Liu C, Wu B, Yang Q, Douglas C, Shaw RJ. An mHealth intervention to improve medication adherence among patients with coronary heart disease in China: development of an intervention. Int J Nursing Sci. (2018) 5:322–30. doi: 10.1016/j.ijnss.2018.09.003
14. Widmer RJ, Collins NM, Collins CS, West CP, Lerman LO, Lerman A. Digital health interventions for the prevention of cardiovascular disease: a systematic review and meta-analysis. Mayo Clin Proc. (2015) 90:469–80. doi: 10.1016/j.mayocp.2014.12.026
15. Gandapur Y, Kianoush S, Kelli HM, Misra S, Urrea B, Blaha MJ, et al. The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic review. Eur Heart J Qual Care Clin Outcomes. (2016) 2:237–44. doi: 10.1093/ehjqcco/qcw018
16. Kozik M, Isakadze N, Martin SS. Mobile health in preventive cardiology: current status and future perspective. Curr Opin Cardiol. (2021) 36:580–8. doi: 10.1097/HCO.0000000000000891
17. The World Health Organization. Recommendations on Digital Interventions for Health System Strengthening. (2019). Available online at: https://www.who.int/publications/i/item/9789241550505 (accessed June 21, 2023).
Keywords: mobile health, mHealth, cardiovascular diseases, strategies, trends, prevention, innovation
Citation: Ni Z, Martini S, Spaulding EM, Hargono A and Martin SS (2023) Editorial: Future trends and directions of using mHealth strategies to prevent and treat cardiovascular diseases. Front. Public Health 11:1246918. doi: 10.3389/fpubh.2023.1246918
Received: 25 June 2023; Accepted: 29 June 2023;
Published: 07 July 2023.
Edited and reviewed by: Mitsunori Ogihara, University of Miami, United States
Copyright © 2023 Ni, Martini, Spaulding, Hargono and Martin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zhao Ni, emhhby5uaSYjeDAwMDQwO3lhbGUuZWR1